Cargando…

Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients

Non-alcoholic steatohepatitis (NASH) is a fast-growing liver disease in the Western world. Currently, only a few animal models show both the metabolic and histological features of human NASH. We aimed to explore murine NASH models in a time dependent manner that exhibit metabolic, histological and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Naomichi, Kato, Sayuka, Tsuchida, Takuma, Sugimoto, Kanami, Saito, Ryuta, Verschuren, Lars, Kleemann, Robert, Oka, Kozo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550083/
https://www.ncbi.nlm.nih.gov/pubmed/31023717
http://dx.doi.org/10.1242/bio.041251
_version_ 1783424125861101568
author Abe, Naomichi
Kato, Sayuka
Tsuchida, Takuma
Sugimoto, Kanami
Saito, Ryuta
Verschuren, Lars
Kleemann, Robert
Oka, Kozo
author_facet Abe, Naomichi
Kato, Sayuka
Tsuchida, Takuma
Sugimoto, Kanami
Saito, Ryuta
Verschuren, Lars
Kleemann, Robert
Oka, Kozo
author_sort Abe, Naomichi
collection PubMed
description Non-alcoholic steatohepatitis (NASH) is a fast-growing liver disease in the Western world. Currently, only a few animal models show both the metabolic and histological features of human NASH. We aimed to explore murine NASH models in a time dependent manner that exhibit metabolic, histological and transcriptomic hallmarks of human NASH. For this, the murine strains C57BL/6J, ob/ob, and KK-A(y) were used and three types of nutritional regimes were administered: normal chow diet (NCD); high-fat, high-fructose, and high-cholesterol diet (fast food diet; FFD); or choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD), for 2, 4, 8, 12, 18, 24, and 30 weeks. All strains under the FFD and CDAHFD regimes developed steatohepatitis. Among the strains treated with FFD, the non-alcoholic fatty liver disease (NAFLD) activity score, fibrosis progression and metabolic abnormalities such as hyperinsulinemia and obesity were more pronounced in ob/ob mice than in C57BL/6J and KK-A(y) mice. In ob/ob mice fed FFD, the development of hepatic crown-like structures was confirmed. Furthermore, molecular pathways involved in steatohepatitis and fibrosis showed significant changes from as early as 2 weeks of starting the FFD regime. Ob/ob mice fed FFD showed metabolic, histological, and transcriptomic dysfunctions similar to human NASH, suggesting their potential as an experimental model to discover novel drugs for NASH.
format Online
Article
Text
id pubmed-6550083
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-65500832019-06-07 Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients Abe, Naomichi Kato, Sayuka Tsuchida, Takuma Sugimoto, Kanami Saito, Ryuta Verschuren, Lars Kleemann, Robert Oka, Kozo Biol Open Research Article Non-alcoholic steatohepatitis (NASH) is a fast-growing liver disease in the Western world. Currently, only a few animal models show both the metabolic and histological features of human NASH. We aimed to explore murine NASH models in a time dependent manner that exhibit metabolic, histological and transcriptomic hallmarks of human NASH. For this, the murine strains C57BL/6J, ob/ob, and KK-A(y) were used and three types of nutritional regimes were administered: normal chow diet (NCD); high-fat, high-fructose, and high-cholesterol diet (fast food diet; FFD); or choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD), for 2, 4, 8, 12, 18, 24, and 30 weeks. All strains under the FFD and CDAHFD regimes developed steatohepatitis. Among the strains treated with FFD, the non-alcoholic fatty liver disease (NAFLD) activity score, fibrosis progression and metabolic abnormalities such as hyperinsulinemia and obesity were more pronounced in ob/ob mice than in C57BL/6J and KK-A(y) mice. In ob/ob mice fed FFD, the development of hepatic crown-like structures was confirmed. Furthermore, molecular pathways involved in steatohepatitis and fibrosis showed significant changes from as early as 2 weeks of starting the FFD regime. Ob/ob mice fed FFD showed metabolic, histological, and transcriptomic dysfunctions similar to human NASH, suggesting their potential as an experimental model to discover novel drugs for NASH. The Company of Biologists Ltd 2019-04-25 /pmc/articles/PMC6550083/ /pubmed/31023717 http://dx.doi.org/10.1242/bio.041251 Text en © 2019. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Research Article
Abe, Naomichi
Kato, Sayuka
Tsuchida, Takuma
Sugimoto, Kanami
Saito, Ryuta
Verschuren, Lars
Kleemann, Robert
Oka, Kozo
Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients
title Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients
title_full Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients
title_fullStr Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients
title_full_unstemmed Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients
title_short Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients
title_sort longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550083/
https://www.ncbi.nlm.nih.gov/pubmed/31023717
http://dx.doi.org/10.1242/bio.041251
work_keys_str_mv AT abenaomichi longitudinalcharacterizationofdietinducedgeneticmurinemodelsofnonalcoholicsteatohepatitiswithmetabolichistologicalandtranscriptomichallmarksofhumanpatients
AT katosayuka longitudinalcharacterizationofdietinducedgeneticmurinemodelsofnonalcoholicsteatohepatitiswithmetabolichistologicalandtranscriptomichallmarksofhumanpatients
AT tsuchidatakuma longitudinalcharacterizationofdietinducedgeneticmurinemodelsofnonalcoholicsteatohepatitiswithmetabolichistologicalandtranscriptomichallmarksofhumanpatients
AT sugimotokanami longitudinalcharacterizationofdietinducedgeneticmurinemodelsofnonalcoholicsteatohepatitiswithmetabolichistologicalandtranscriptomichallmarksofhumanpatients
AT saitoryuta longitudinalcharacterizationofdietinducedgeneticmurinemodelsofnonalcoholicsteatohepatitiswithmetabolichistologicalandtranscriptomichallmarksofhumanpatients
AT verschurenlars longitudinalcharacterizationofdietinducedgeneticmurinemodelsofnonalcoholicsteatohepatitiswithmetabolichistologicalandtranscriptomichallmarksofhumanpatients
AT kleemannrobert longitudinalcharacterizationofdietinducedgeneticmurinemodelsofnonalcoholicsteatohepatitiswithmetabolichistologicalandtranscriptomichallmarksofhumanpatients
AT okakozo longitudinalcharacterizationofdietinducedgeneticmurinemodelsofnonalcoholicsteatohepatitiswithmetabolichistologicalandtranscriptomichallmarksofhumanpatients